News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Immune Control Inc. Enrolls $5 Million As It Shifts Focus To Asthma Treatment



8/14/2009 10:05:19 AM

VentureWire -- Immune Control Inc., which aims to control immune-cell activity through drugs targeting serotonin receptors, has ceased development of its Phase Ib multiple myeloma drug and has now turned its attention to developing a new, oral treatment for asthma....



comments powered by Disqus
   
Asthma

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES